Gautam Chukka
Stock Analyst at Chardan Capital
(0.47)
# 4,366
Out of 5,020 analysts
5
Total ratings
n/a
Success rate
-36.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gautam Chukka
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $132.73 | +80.82% | 1 | Sep 21, 2026 | |
| ADAG Adagene | Initiated Coverage: Buy | $9 | $2.93 | +207.17% | 1 | Sep 10, 2026 | |
| TENX Tenax Therapeutics | Downgraded: Hold | $27 → $5 | $1.93 | +159.07% | 3 | Aug 11, 2026 |
Palvella Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $240
Current: $132.73
Upside: +80.82%
Adagene
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $2.93
Upside: +207.17%
Tenax Therapeutics
Aug 11, 2026
Downgraded: Hold
Price Target: $27 → $5
Current: $1.93
Upside: +159.07%